{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:50:34Z","timestamp":1780599034554,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Overactive bladder (OAB) is an intricate disorder with an unclear pathophysiological relationship with inflammation. This study employs the Systemic Inflammation Response Index (SIRI) as a quantitative measure of systemic inflammatory status and explores its association with both the risk and severity of OAB, as assessed by the Overactive Bladder Symptom Score (OABSS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Population data from the National Health and Nutrition Examination Survey (NHANES) in 2005\u20132020 were extracted. Weighted logistic regression and weighted linear regression models were utilized to examine the relation of SIRI to OAB risk and OABSS. The possible nonlinear relation of SIRI to clinical outcomes was examined via restricted cubic spline (RCS) models. In addition, subgroup analyses and interaction tests helped to explore the consistency of these associations across subpopulations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>23,915 individuals were encompassed for our analysis. 9011 (21%) were diagnosed with OAB. Both weighted linear and logistic regression analyses demonstrated a significant link of SIRI to OAB risk and symptom severity (fully adjusted model: <jats:italic>\u03b2<\/jats:italic>\u2009=\u20090.143, 95% CI 0.086\u20130.200, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001; OR\u2009=\u20091.268, 95% CI 1.122\u20131.413, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The RCS model showed a significant nonlinear relation of SIRI to clinical outcomes. Subgroup analyses further demonstrated the consistency of these associations across various subgroups.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>SIRI is a significant risk factor for OAB, and higher SIRI levels are strongly related to heightened OAB symptom severity.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40001-025-02773-3","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T02:30:42Z","timestamp":1750041042000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The association between the systemic inflammation response index and overactive bladder: a cross-sectional study"],"prefix":"10.1186","volume":"30","author":[{"given":"Liandong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xier","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"2773_CR1","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jad.2024.04.030","volume":"356","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Wu X, Liu G, Feng X, Jiang H, Zhang X. Association between overactive bladder and depression in American adults: a cross-sectional study from NHANES 2005\u20132018. J Affect Disord. 2024;356:545\u201353. https:\/\/doi.org\/10.1016\/j.jad.2024.04.030.","journal-title":"J Affect Disord"},{"issue":"8","key":"2773_CR2","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/j.1742-1241.2009.02078.x","volume":"63","author":"JF Wyman","year":"2009","unstructured":"Wyman JF, Burgio KL, Newman DK. Practical aspects of lifestyle modifications and behavioural interventions in the treatment of overactive bladder and urgency urinary incontinence. Int J Clin Pract. 2009;63(8):1177\u201391. https:\/\/doi.org\/10.1111\/j.1742-1241.2009.02078.x.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"2773_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","volume":"20","author":"WF Stewart","year":"2003","unstructured":"Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327\u201336. https:\/\/doi.org\/10.1007\/s00345-002-0301-4.","journal-title":"World J Urol"},{"issue":"7","key":"2773_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1079\/phn2004627","volume":"7","author":"HM Dallosso","year":"2004","unstructured":"Dallosso HM, Matthews RJ, McGrother CW, Donaldson MM, Shaw C. The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men. Public Health Nutr. 2004;7(7):885\u201391. https:\/\/doi.org\/10.1079\/phn2004627.","journal-title":"Public Health Nutr"},{"issue":"14","key":"2773_CR5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.purol.2020.08.003","volume":"30","author":"X Gam\u00e9","year":"2020","unstructured":"Gam\u00e9 X, Ph\u00e9 V. Pathophysiology of overactive bladder. Prog Urol. 2020;30(14):873\u20139. https:\/\/doi.org\/10.1016\/j.purol.2020.08.003.","journal-title":"Prog Urol"},{"issue":"11 Suppl","key":"2773_CR6","first-page":"S580","volume":"6","author":"P Abrams","year":"2000","unstructured":"Abrams P, Kelleher CJ, Kerr LA, Rogers RG. Overactive bladder significantly affects quality of life. Am J Manag Care. 2000;6(11 Suppl):S580\u201390.","journal-title":"Am J Manag Care"},{"issue":"6 Suppl 1","key":"2773_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.urology.2004.10.047","volume":"64","author":"A Tubaro","year":"2004","unstructured":"Tubaro A. Defining overactive bladder: epidemiology and burden of disease. Urology. 2004;64(6 Suppl 1):2\u20136. https:\/\/doi.org\/10.1016\/j.urology.2004.10.047.","journal-title":"Urology"},{"key":"2773_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.intimp.2018.10.002","volume":"65","author":"Y Geng","year":"2018","unstructured":"Geng Y, Zhu D, Wu C, Wu J, Wang Q, Li R, et al. A novel systemic inflammation response index (SIRI) for predicting postoperative survival of patients with esophageal squamous cell carcinoma. Int Immunopharmacol. 2018;65:503\u201310. https:\/\/doi.org\/10.1016\/j.intimp.2018.10.002.","journal-title":"Int Immunopharmacol"},{"key":"2773_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.intimp.2018.08.022","volume":"64","author":"Y Huang","year":"2018","unstructured":"Huang Y, Liu A, Liang L, Jiang J, Luo H, Deng W, et al. Diagnostic value of blood parameters for community-acquired pneumonia. Int Immunopharmacol. 2018;64:10\u20135. https:\/\/doi.org\/10.1016\/j.intimp.2018.08.022.","journal-title":"Int Immunopharmacol"},{"issue":"23","key":"2773_CR10","doi-asserted-by":"publisher","first-page":"6212","DOI":"10.1158\/1078-0432.Ccr-14-0442","volume":"20","author":"B Hu","year":"2014","unstructured":"Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212\u201322. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0442.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2773_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12967-019-1782-x","volume":"17","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hua YQ, Wang D, Chen LY, Wu CJ, Chen Z, et al. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer. J Transl Med. 2019;17(1):30. https:\/\/doi.org\/10.1186\/s12967-019-1782-x.","journal-title":"J Transl Med"},{"issue":"3","key":"2773_CR12","doi-asserted-by":"publisher","first-page":"300060524123575","DOI":"10.1177\/03000605241235758","volume":"52","author":"J Tang","year":"2024","unstructured":"Tang J, Zhong Z, Nijiati M, Wu C. Systemic inflammation response index as a prognostic factor for patients with sepsis-associated acute kidney injury: a retrospective observational study. J Int Med Res. 2024;52(3):3000605241235758. https:\/\/doi.org\/10.1177\/03000605241235758.","journal-title":"J Int Med Res"},{"key":"2773_CR13","doi-asserted-by":"publisher","first-page":"1386639","DOI":"10.3389\/fendo.2024.1386639","volume":"15","author":"Q He","year":"2024","unstructured":"He Q, Wu L, Deng C, He J, Wen J, Wei C, et al. Diabetes mellitus, systemic inflammation and overactive bladder. Front Endocrinol (Lausanne). 2024;15:1386639. https:\/\/doi.org\/10.3389\/fendo.2024.1386639.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"2773_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1152\/physrev.00030.2012","volume":"93","author":"L Birder","year":"2013","unstructured":"Birder L, Andersson KE. Urothelial signaling. Physiol Rev. 2013;93(2):653\u201380. https:\/\/doi.org\/10.1152\/physrev.00030.2012.","journal-title":"Physiol Rev"},{"key":"2773_CR15","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/120525","volume":"2014","author":"EJ Gonzalez","year":"2014","unstructured":"Gonzalez EJ, Arms L, Vizzard MA. The role(s) of cytokines\/chemokines in urinary bladder inflammation and dysfunction. Biomed Res Int. 2014;2014: 120525. https:\/\/doi.org\/10.1155\/2014\/120525.","journal-title":"Biomed Res Int"},{"key":"2773_CR16","doi-asserted-by":"publisher","first-page":"1338025","DOI":"10.3389\/fimmu.2024.1338025","volume":"15","author":"L Gu","year":"2024","unstructured":"Gu L, Xia Z, Qing B, Wang W, Chen H, Wang J, et al. Systemic Inflammatory Response Index (SIRI) is associated with all-cause mortality and cardiovascular mortality in population with chronic kidney disease: evidence from NHANES (2001\u20132018). Front Immunol. 2024;15:1338025. https:\/\/doi.org\/10.3389\/fimmu.2024.1338025.","journal-title":"Front Immunol"},{"issue":"Suppl","key":"2773_CR17","first-page":"8","volume":"18","author":"J Barkin","year":"2011","unstructured":"Barkin J. Overactive bladder. Can J Urol. 2011;18(Suppl):8\u201313.","journal-title":"Can J Urol"},{"issue":"2","key":"2773_CR18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.juro.2007.03.133","volume":"178","author":"JG Blaivas","year":"2007","unstructured":"Blaivas JG, Panagopoulos G, Weiss JP, Somaroo C. Validation of the overactive bladder symptom score. J Urol. 2007;178(2):543\u20137. https:\/\/doi.org\/10.1016\/j.juro.2007.03.133. (discussion 7).","journal-title":"J Urol"},{"issue":"1","key":"2773_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.amjmed.2022.08.031","volume":"136","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wang Z, Tao Z, Wang S, Wang Z. Relationship between marijuana use and overactive bladder (OAB): a cross-sectional research of NHANES 2005 to 2018. Am J Med. 2023;136(1):72\u20138. https:\/\/doi.org\/10.1016\/j.amjmed.2022.08.031.","journal-title":"Am J Med"},{"key":"2773_CR20","doi-asserted-by":"publisher","first-page":"1137191","DOI":"10.3389\/fpubh.2023.1137191","volume":"11","author":"Y Xiao","year":"2023","unstructured":"Xiao Y, Yin S, Wang J, Cui J, Yang Z, Wang J, et al. A positive association between the prevalence of circadian syndrome and overactive bladder in United States adults. Front Public Health. 2023;11:1137191. https:\/\/doi.org\/10.3389\/fpubh.2023.1137191.","journal-title":"Front Public Health"},{"key":"2773_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/rru.S102441","volume":"8","author":"RS Eapen","year":"2016","unstructured":"Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71\u20136. https:\/\/doi.org\/10.2147\/rru.S102441.","journal-title":"Res Rep Urol"},{"issue":"Suppl 1","key":"2773_CR22","first-page":"2","volume":"23","author":"RS Eapen","year":"2016","unstructured":"Eapen RS, Radomski SB. Gender differences in overactive bladder. Can J Urol. 2016;23(Suppl 1):2\u20139.","journal-title":"Can J Urol"},{"issue":"7203","key":"2773_CR23","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335. https:\/\/doi.org\/10.1038\/nature07201.","journal-title":"Nature"},{"key":"2773_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2025.02.002","author":"L Li","year":"2025","unstructured":"Li L, Jiao Q, Yang Q, Lu H, Zhou X, Zhang Q, et al. A bladder-blood immune barrier constituted by suburothelial perivascular macrophages restrains uropathogen dissemination. Immunity. 2025. https:\/\/doi.org\/10.1016\/j.immuni.2025.02.002.","journal-title":"Immunity"},{"key":"2773_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094483","author":"P Wigner","year":"2021","unstructured":"Wigner P, Gr\u0119bowski R, Bijak M, Saluk-Bijak J, Szemraj J. The interplay between oxidative stress, inflammation and angiogenesis in bladder cancer development. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094483.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2773_CR26","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/bph.12958","volume":"172","author":"A Coelho","year":"2015","unstructured":"Coelho A, Wolf-Johnston AS, Shinde S, Cruz CD, Cruz F, Avelino A, et al. Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels. Br J Pharmacol. 2015;172(7):1691\u20139. https:\/\/doi.org\/10.1111\/bph.12958.","journal-title":"Br J Pharmacol"},{"issue":"5","key":"2773_CR27","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1038\/s41416-023-02552-z","volume":"130","author":"Y Ouyang","year":"2024","unstructured":"Ouyang Y, Zhong W, Xu P, Wang B, Zhang L, Yang M, et al. Tumor-associated neutrophils suppress CD8(+) T cell immunity in urothelial bladder carcinoma through the COX-2\/PGE2\/IDO1 axis. Br J Cancer. 2024;130(5):880\u201391. https:\/\/doi.org\/10.1038\/s41416-023-02552-z.","journal-title":"Br J Cancer"},{"key":"2773_CR28","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3389\/fnins.2018.00931","volume":"12","author":"L Grundy","year":"2018","unstructured":"Grundy L, Caldwell A, Brierley SM. Mechanisms underlying overactive bladder and interstitial cystitis\/painful bladder syndrome. Front Neurosci. 2018;12:931. https:\/\/doi.org\/10.3389\/fnins.2018.00931.","journal-title":"Front Neurosci"},{"issue":"4","key":"2773_CR29","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s11934-008-0054-8","volume":"9","author":"R Saini","year":"2008","unstructured":"Saini R, Gonzalez RR, Te AE. Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link. Curr Urol Rep. 2008;9(4):314\u20139. https:\/\/doi.org\/10.1007\/s11934-008-0054-8.","journal-title":"Curr Urol Rep"},{"issue":"12","key":"2773_CR30","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/s0929-6646(10)60133-7","volume":"109","author":"HT Liu","year":"2010","unstructured":"Liu HT, Chen CY, Kuo HC. Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders. J Formos Med Assoc. 2010;109(12):862\u201378. https:\/\/doi.org\/10.1016\/s0929-6646(10)60133-7.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"2773_CR31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/tcmj.tcmj_38_20","volume":"33","author":"QS Ke","year":"2021","unstructured":"Ke QS, Lee CL, Kuo HC. Recurrent urinary tract infection in women and overactive bladder - Is there a relationship? Tzu Chi Med J. 2021;33(1):13\u201321. https:\/\/doi.org\/10.4103\/tcmj.tcmj_38_20.","journal-title":"Tzu Chi Med J"},{"issue":"1","key":"2773_CR32","doi-asserted-by":"publisher","first-page":"2337729","DOI":"10.1080\/07853890.2024.2337729","volume":"56","author":"S Zhang","year":"2024","unstructured":"Zhang S, Cheng T. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis. Ann Med. 2024;56(1):2337729. https:\/\/doi.org\/10.1080\/07853890.2024.2337729.","journal-title":"Ann Med"},{"key":"2773_CR33","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.2147\/cia.S339221","volume":"16","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Xing Z, Zhou K, Jiang S. The predictive role of Systemic Inflammation Response Index (SIRI) in the prognosis of stroke patients. Clin Interv Aging. 2021;16:1997\u20132007. https:\/\/doi.org\/10.2147\/cia.S339221.","journal-title":"Clin Interv Aging"},{"key":"2773_CR34","doi-asserted-by":"publisher","first-page":"1329256","DOI":"10.3389\/fendo.2024.1329256","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, Cui L, Xu H. Association between systemic inflammation response index and chronic kidney disease: a population-based study. Front Endocrinol (Lausanne). 2024;15:1329256. https:\/\/doi.org\/10.3389\/fendo.2024.1329256.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2773_CR35","doi-asserted-by":"publisher","first-page":"1100453","DOI":"10.3389\/fendo.2023.1100453","volume":"14","author":"Y Song","year":"2023","unstructured":"Song Y, Zhao Y, Shu Y, Zhang L, Cheng W, Wang L, et al. Combination model of neutrophil to high-density lipoprotein ratio and system inflammation response index is more valuable for predicting peripheral arterial disease in type 2 diabetic patients: a cross-sectional study. Front Endocrinol (Lausanne). 2023;14:1100453. https:\/\/doi.org\/10.3389\/fendo.2023.1100453.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"2773_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/nau.20938","volume":"30","author":"SD Chung","year":"2011","unstructured":"Chung SD, Liu HT, Lin H, Kuo HC. Elevation of serum c-reactive protein in patients with OAB and IC\/BPS implies chronic inflammation in the urinary bladder. Neurourol Urodyn. 2011;30(3):417\u201320. https:\/\/doi.org\/10.1002\/nau.20938.","journal-title":"Neurourol Urodyn"},{"issue":"10","key":"2773_CR37","doi-asserted-by":"publisher","first-page":"568","DOI":"10.5603\/GP.a2017.0102","volume":"88","author":"AF Wr\u00f3bel","year":"2017","unstructured":"Wr\u00f3bel AF, Kluz T, Surkont G, Wla\u017alak E, Skorupski P, Filipczak A, et al. Novel biomarkers of overactive bladder syndrome. Ginekol Pol. 2017;88(10):568\u201373. https:\/\/doi.org\/10.5603\/GP.a2017.0102.","journal-title":"Ginekol Pol"},{"issue":"10","key":"2773_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048309","volume":"11","author":"S Kim","year":"2021","unstructured":"Kim S, Park JH, Oh YH, Kim HJ, Kong MH, Moon J. Correlation between neutrophil to lymphocyte ratio and overactive bladder in South Korean women: a community-based, cross-sectional study. BMJ Open. 2021;11(10): e048309. https:\/\/doi.org\/10.1136\/bmjopen-2020-048309.","journal-title":"BMJ Open"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-02773-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-02773-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T15:02:31Z","timestamp":1750086151000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-02773-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2773"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-02773-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES program has been approved by the NCHS Ethics Review Board. Furthermore, patient information in this database has been anonymized, thereby obviating the need for informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"481"}}